What are the economic implications of using the Integrated Approach for HIV, Syphilis and Hepatitis B Management versus Standard of Care at Point-of-Care Settings in Zimbabwe?

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202605801050672

Enrollment

284

Registered

2026-05-28

Start date

2025-07-31

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV/AIDS Syphilis and Hepatitis B Pregnancy and Childbirth

Interventions

Testing for HIV and Syphilis simultaneously and Hepatitis B seperately

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. Age 18 or older, unless if they are emancipated minors. 2. Pregnant women only will be included in the study if they consent. 3. Written informed consent given by the subject. 4. The subject agrees that all aspects of the study will be completed. 5. The subject presents to a participating centre. This presentation may be by invitation to the study.

Exclusion criteria

Exclusion criteria: 1. The subject has already participated in this study at a previous date. 2. The subject is currently enrolled in a study to evaluate an investigational new drug and has started taking the investigational drug. 3. Vulnerable populations as deemed inappropriate for the study by the study Investigator(s) such as those who are not mentally competent to take part in the study.

Design outcomes

Primary

Measure	Time frame
Morbidity	—

Secondary

Measure	Time frame
Disability-Adjusted Life Years (DALYs) Averted, Incremental Cost-Effectiveness Ratio (ICER) and Benefit-Cost Ratio (BCR)	—

Countries

Zimbabwe

Contacts

Public ContactPisirai Ndarukwa

Public Health Specialist

papandarukwa@gmail.com+263773012397

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026